Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    January 2017

  1. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    AIDS. 2017;31:375-384.
    PubMed     Text format     Abstract available


    November 2016
  2. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    PubMed     Text format     Abstract available


    October 2016
  3. VAN DER WERF MJ, Kodmon C, Zucs P, Hollo V, et al
    Tuberculosis and HIV co-infection in Europe: looking at one reality from two angles.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    August 2016
  4. HIRA S, Piot P
    The counter effects of the ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa.
    AIDS. 2016.
    PubMed     Text format    


    June 2016
  5. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
    AIDS. 2016;30:1607-15.
    PubMed     Text format     Abstract available


    March 2016
  6. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  7. SUMNER T, Houben RM, Rangaka MX, Maartens G, et al
    Post-Treatment Effect of Isoniazid Preventive Therapy on Tuberculosis Incidence in Hiv-Infected Individuals on Antiretroviral Therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    January 2016
  8. MARAIS S, Meintjes G, Lesosky M, Wilkinson KA, et al
    Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    AIDS. 2016;30:395-404.
    PubMed     Text format     Abstract available


  9. KARO B, Krause G, Hollo V, van der Werf MJ, et al
    The impact of HIV infection on treatment outcome of tuberculosis: analysis of surveillance data from nine European countries, 2010-2012.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  10. BOON SD, Matteelli A, Ford N, Getahun H, et al
    Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    November 2015
  11. BACHMANN MO, Timmerman V, Fairall LR
    Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.
    AIDS. 2015;29:2261-8.
    PubMed     Text format     Abstract available


    September 2015
  12. YOTEBIENG M, Edmonds A, Lelo P, Wenzi LK, et al
    High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo.
    AIDS. 2015;29:2055-7.
    PubMed     Text format     Abstract available


    August 2015
  13. GUPTA RK, Lucas SB, Fielding KL, Lawn SD, et al
    Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.
    AIDS. 2015.
    PubMed     Text format     Abstract available


    July 2015
  14. JOSEPH JP, Jerome G, Lambert W, Almazor P, et al
    Going beyond the vertical: leveraging a national HIV quality improvement programme to address other health priorities in Haiti.
    AIDS. 2015;29 Suppl 2:S165-73.
    PubMed     Text format     Abstract available


    June 2015
  15. GUPTA RK, Brown AE, Zenner D, Rice B, et al
    CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  16. LIU E, Makubi A, Drain P, Spiegelman D, et al
    Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  17. RICHAUD C, Ghosn J, Amazzough K, Poiree S, et al
    Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS.
    AIDS. 2015;29:1117-9.
    PubMed     Text format    


    January 2015
  18. SAMANDARI T, Agizew TB, Nyirenda S, Tedla Z, et al
    Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.
    AIDS. 2015;29:351-9.
    PubMed     Text format     Abstract available


  19. JONES CE, Hesseling AC, Tena-Coki NG, Scriba TJ, et al
    The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guerin vaccination.
    AIDS. 2015;29:155-65.
    PubMed     Text format     Abstract available


  20. TAN HY, Yong YK, Andrade BB, Shankar EM, et al
    Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
    AIDS. 2015.
    PubMed     Text format     Abstract available


    December 2014
  21. HARIDAS V, Pean P, Jasenosky LD, Madec Y, et al
    TB-IRIS and remodelling of the T-cell compartment in highly immunosuppressed HIV+ patients with TB: the CAPRI-T (ANRS-12614) study.
    AIDS. 2014.
    PubMed     Text format     Abstract available


    November 2014
  22. DAFTARY A, Calzavara L, Padayatchi N
    The contrasting cultures of HIV and tuberculosis care.
    AIDS. 2014.
    PubMed     Text format     Abstract available


  23. PRETORIUS C, Glaziou P, Dodd PJ, White R, et al
    Using the TIME model in Spectrum to estimate tuberculosis-HIV incidence and mortality.
    AIDS. 2014;28 Suppl 4:S477-S487.
    PubMed     Text format     Abstract available


    March 2014
  24. SUTHAR AB, Rutherford GW, Horvath T, Doherty MC, et al
    Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization.
    AIDS. 2014;28 Suppl 2:S175-85.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: